BASECARE-B (02170) experienced a sharp decline in the stock market, plummeting 12.37% during Monday's trading session. The significant drop comes on the heels of the company's release of its interim financial results for 2025, which revealed disappointing performance metrics.

According to the interim report, BASECARE-B's group revenue fell to RMB 101 million, marking an 18.76% year-over-year decrease. More concerning for investors, the loss attributable to shareholders expanded to RMB 121 million, representing a 1.31% increase compared to the same period last year. This combination of shrinking revenue and growing losses has clearly shaken investor confidence.

The company attributed the decline in revenue to an overall slowdown in industry growth, which has negatively impacted the group's performance. In an attempt to improve overall profit levels, BASECARE-B stated that it had proactively contracted certain projects with relatively lower profitability during the year. However, this strategy appears to have failed to offset the broader challenges facing the company, as reflected in the stock's sharp decline following the release of these results.